| # | Drug | Count |
|---|---|---|
| 0 | IBUPROFEN | 92 |
| 1 | IBUPFROFEN | 81 |
| 2 | IBUPROFEN 200 MG | 81 |
| 3 | IBUPROFEN 200MG | 81 |
| 4 | IBUPROFEN CAPSULE | 81 |
| 5 | IBUPROFEN CAPSULES 200 MG | 81 |
| 6 | IBUPROFEN ORAL | 81 |
| 7 | IBUPROFEN TABLET, FILM COATED | 81 |
| 8 | IBUPROFEN TABLET, FILM-COATED | 81 |
| 9 | IBUPROFEN TABLETS USP, 200MG | 81 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0119 |
| 2 | TECOVIRIMAT MONOHYDRATE | 1 | 0.0096 |
| 3 | L-TYROSINE | 1 | 0.0074 |
| 4 | ZIV-AFLIBERCEPT | 6 | 0.0046 |
| 5 | POTASSIUM ACETATE | 6 | 0.0041 |
| 6 | INFLIXIMAB-DYYB | 13 | 0.0038 |
| 7 | GRISEOFULVIN | 1 | 0.0034 |
| 8 | VON WILLEBRAND FACTOR (RECOMBINANT) | 1 | 0.0032 |
| 9 | OLOPATADINE HCL | 1 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 154 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 2 | Corticosteroid [EPC] | 86 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 67 |
| 4 | Interleukin-17A Antagonist [EPC] | 33 |
| 5 | Interleukin-23 Antagonist [EPC] | 33 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 7 | Vitamin C [EPC] | 28 |
| 8 | Interleukin-12 Antagonist [EPC] | 25 |
| 9 | Benzodiazepine [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 1 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 5 | Interleukin-17A Antagonist [EPC] | 33 | 0.0009 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |